Targeting FcRn in generalized myasthenia gravis with rozanolixizumab-noli

Includes a Live Web Event on 02/18/2026 at 1:00 PM (EST)

image

This session will cover rozanolixizumab-noli, a subcutaneous infusion that blocks neonatal Fc receptor (FcRn), in the management of anti-acetylcholine receptor (AChR) or anti-muscle-specific tyrosine kinase (MuSK) antibody positive (Ab+) generalized myasthenia gravis (gMG) in adults. Within the evolving gMG treatment landscape, understanding its clinical application is key to supporting shared decision-making that aligns with patients’ unique needs and preferences. Learners will explore best practices for administration and review recent data from the Phase 3 MycarinG and extension studies. In this session, we will apply clinical insights to a patient case and explore practical strategies for incorporating rozanolixizumab-noli into treatment plans for adults with anti-AChR or anti-MuSK Ab+ gMG.

Learning Objectives: At the conclusion of this session, learners will be able to: 

  • Apply best practices for the administration of rozanolixizumab-noli
  • Analyze and interpret recent clinical trial data for rozanolixizumab-noli in adults with anti-AChR or anti-MuSK Ab+ gMG
  • Personalize treatment strategies and goals using a patient case with gMG to foster critical thinking

This webinar does not offer any continuing education credits or recertification units. 

Deena Rodney, MSN, APRN, ATC, AQH

Deena M. Rodney, MSN, APRN, ATC, AQH, started her nursing career as a bedside neurology and psychiatric nurse. Shortly into her career, she transitioned to a unit educator for the neuroscience department (neurology medicine, surgical, and intensive care unit [ICU]). She found her strength in educating and grew into an administrator position developing graduate nurse programs for specialty units and training preceptors. Ms Rodney also held her roots to neurology, and post-graduate, accepted her current position of 16 years as community neurology APRN, caring for general neurology patients and rounding at one of the largest hospitals in central Florida. As she honed her profession, she developed a strength in care for the neuromuscular patient. In her practice, Ms Rodney is able to manage all aspects of patient care, including involvement in research and monitoring patients in the infusion suite. She has a mutual passion to care for the whole person and to educate providers.

Key:

Complete
Failed
Available
Locked
Targeting FcRn in generalized myasthenia gravis with rozanolixizumab-noli
Live event: 02/18/2026 at 1:00 PM (EST) You must register to access.
Webinar Evaluation